What’s New on the Legal Front in Life Sciences?

Tuesday, October 31 1:00 PM EDT to 1:45 PM EDT


A major pharmaceutical company is hit with a cyberattack—what are its responsibilities? The opioid epidemic shines a spotlight on drug manufacturers—how should they respond? The life sciences legal landscape is constantly changing, which is why it’s important to remain engaged on the latest news and trends.

Building on the success of our last life sciences teleconference, please join us for our next complimentary 45-minute teleconference.

During the call, we will discuss:

  • Reconciling IP protection and access to medicines: A client's perspective

  • Building a compliant opioids marketing program

  • Protecting your business from current cybersecurity threats

We will take questions from participants at the end of the call. In addition, you are encouraged to send us any questions in advance. 

Confirmed speakers include:

Donna M. MeuthEisai Inc., Intellectual Property, Associate General Counsel

**Bruce M. Wexler** (Moderator)Paul Hastings, Intellectual Property, Life Sciences Practice Chair

Jane YoonPaul Hastings, Investigations & White Collar, Life Sciences, Of Counsel

Robert P. SilversPaul Hastings, Privacy & Cybersecurity and Investigations & White Collar, Partner

To register and for event information, please contact:Ngar Eldredgengareldredge@paulhastings.com202.551.1297

Teleconference dial in details will be sent with the event confirmation.

Practice Areas

Life Sciences and Healthcare


Image: Jane H. Yoon
Jane H. Yoon

Partner, Litigation Department

Image: Bruce M. Wexler
Bruce M. Wexler

Partner, Litigation Department

Get In Touch With Us

Contact Us